Maropitant for Conures: Uses, Dosing & Side Effects

This information is for educational purposes only. Never give your pet any medication without your veterinarian's guidance. Dosing, frequency, and safety depend on your pet's specific health profile.

Maropitant is a prescription anti-nausea medication best known by the brand name Cerenia. It works by blocking substance P at NK1 receptors, which helps reduce signals involved in nausea and vomiting. In veterinary medicine, it is FDA-approved for dogs and cats, but use in birds, including conures, is extra-label. That means your vet may prescribe it when they believe it fits your bird's needs, even though the label was not written for avian patients.

In conures, maropitant is usually considered a supportive-care medication, not a cure for the underlying problem. A bird that is vomiting, regurgitating, fluffed up, losing weight, or refusing food still needs a diagnostic plan. Your vet may use maropitant while also looking for causes such as crop disease, gastrointestinal inflammation, toxin exposure, heavy metal problems, infection, or systemic illness.

Avian evidence is still developing. Recent pharmacokinetic work in psittacine birds found that a single 1 mg/kg dose was well tolerated, but blood levels dropped fairly quickly, suggesting that dosing schedules borrowed from dogs may not always produce the same effect in parrots. That is one reason dosing should be individualized by an avian veterinarian rather than copied from mammal instructions.

Your vet may consider maropitant for a conure with suspected nausea, repeated vomiting, or regurgitation when controlling those signs could improve comfort and help the bird keep down fluids, hand-feeding formula, or other medications. It may be used during workups for crop stasis, gastrointestinal irritation, pancreatobiliary disease, systemic infection, or other illnesses where nausea is part of the picture.

It can also be part of a broader supportive-care plan around hospitalization, imaging, anesthesia, or transport stress in selected patients. In mammals, maropitant is widely used for vomiting and motion sickness. In birds, however, the evidence base is smaller, so your vet is often making a careful clinical judgment rather than following a fully established avian label.

Maropitant is not a substitute for diagnosing the cause of vomiting-like behavior. In parrots, true vomiting, regurgitation, and courtship feeding can look similar to pet parents. Because those signs can overlap, your vet may ask for videos, weight trends, droppings history, diet details, and recent exposure risks before deciding whether maropitant is appropriate.

There is no one standard conure dose that is proven for every case. In dogs and cats, common labeled doses are 1 mg/kg by injection or 2 mg/kg by mouth once daily for acute vomiting, with a higher oral dose used for motion sickness in dogs. In birds, those mammal doses are often used only as a starting reference point, not a final answer.

Published avian research has evaluated 1 mg/kg subcutaneously and intravenously in Amazon parrots and 1 to 2 mg/kg subcutaneously in chickens. Those studies suggest maropitant is absorbed in birds, but it may clear faster than expected, which means the ideal avian dose interval is still unsettled. For a small parrot like a conure, even tiny measuring errors can matter, so your vet may prefer an in-hospital injection, a carefully compounded liquid, or a precisely divided oral plan.

Never calculate a conure dose from a dog tablet at home. Conures often weigh only 60 to 90 grams, so a small fraction of a tablet can become a large overdose. If your bird spits out medication, vomits after dosing, seems weaker, or you think too much was given, contact your vet promptly for next-step guidance.

Many birds tolerate maropitant reasonably well when it is prescribed carefully, but side effects are still possible. The most practical concerns in conures are stress with handling, pain at the injection site, and changes that may be hard to separate from the underlying illness, such as quiet behavior, reduced appetite, or ongoing gastrointestinal upset.

In dogs and cats, reported side effects include drooling, diarrhea, decreased appetite, lethargy, and vomiting after dosing. Injection discomfort is well recognized, and rapid intravenous administration can cause serious blood pressure effects in mammals. Avian-specific safety data are limited, so your vet may monitor your bird more closely if maropitant is being used in a fragile patient, a dehydrated bird, or one with liver concerns.

See your vet immediately if your conure becomes very weak, has trouble perching, shows labored breathing, develops worsening vomiting or regurgitation, has black or bloody droppings, or stops eating. In birds, those changes can become urgent quickly, even if the medication itself is not the only cause.

Maropitant should always be reviewed in the context of your conure's full medication list. In mammals, it is metabolized by the liver, so your vet may use added caution when combining it with other drugs that rely heavily on hepatic metabolism or when liver disease is suspected. That does not always mean the combination is unsafe. It means the plan may need closer monitoring.

Potential interaction concerns are most relevant when maropitant is used alongside sedatives, anesthetic drugs, pain medications, antifungals, or other supportive-care medications in a sick bird. The issue is often not a single forbidden pairing, but the combined effect on a small, medically fragile patient. If your conure is receiving multiple oral medications, your vet may also space doses to reduce handling stress and improve absorption.

Tell your vet about every product your bird receives, including compounded medications, supplements, probiotics, and anything mixed into food. Do not add over-the-counter nausea remedies or human medications unless your vet specifically tells you to.